05:02pm Deutsche Bank Cuts Tesla Price Target to $420 From $465, Maintains Buy Rating MT
04:59pm Lakeland Financial's Q2 Earnings, Revenue Rise MT
04:59pm Alliance Resource Partners Q2 Earnings, Revenue Rise MT
04:48pm China's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial RE
04:44pm Raymond James Lifts Price Target on United Bankshares to $52 From $50, Keeps Outperform Rating MT
04:44pm Nomura Adjusts VNET Group Price Target to $13 From $14.10, Maintains Buy Rating MT
04:43pm Wedbush Raises Price Target on Western Digital to $650 From $540, Keeps Outperform Rating MT
04:42pm Earnings Flash (LKFN) Lakeland Financial Posts Q2 EPS $1.13, vs. FactSet Est of $1.08 MT
04:41pm Earnings Flash (LKFN) Lakeland Financial Corporation Reports Q2 Revenue $70.9M, vs. FactSet Est of $72.1M MT
04:41pm Earnings Flash (ARLP) Alliance Resource Partners Posts Q2 Earnings $0.61 a Unit, vs. FactSet Est of $0.62 MT
04:41pm Earnings Flash (ARLP) Alliance Resource Partners, L.P. Reports Q2 Revenue $551.6M, vs. FactSet Est of $554.3M MT
04:40pm United Therapeutics Insider Sold Shares Worth $5,051,519, According to a Recent SEC Filing MT
04:40pm Wedbush Raises Price Target on Seagate Technology to $1,000 From $825, Keeps Outperform Rating MT
04:19pm Synopsys Unveils Autonomous AI Engineering Tools With Nvidia MT
04:18pm Social Buzz: Wallstreetbets Stocks Advance Premarket Monday; AST SpaceMobile, Micron Technology to Open Higher MT
04:02pm Credit Acceptance Chief Technology Officer Ravi Mohan to Step Down in August MT
04:02pm Citigroup Adjusts Price Target on Comcast to $30 From $32, Maintains Buy Rating MT
04:01pm JPMorgan Adjusts Price Target on Ross Stores to $262 From $265, Maintains Overweight Rating MT
04:00pm Ensign Group Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Outlook MT
03:59pm (ENSG) Ensign Expects 2026 Revenue Range $5.87B to $5.92B, vs. FactSet Est of $5.84B MT
03:59pm (ENSG) Ensign Expects 2026 EPS Range $7.75 to $7.85 MT
03:40pm Earnings Flash (ENSG) The Ensign Group, Inc. Reports Q2 Revenue $1.44B, vs. FactSet Est of $1.44B MT
03:39pm Earnings Flash (ENSG) The Ensign Group, Inc. Posts Q2 Adjusted EPS $1.92 per Share, vs. FactSet Est of $1.85 MT
03:37pm AstraZeneca Q2 Core Earnings, Revenue Rise; Interim Dividend Raised MT
03:25pm Goldman Sachs Adjusts Price Target on Apple to $370 From $340, Maintains Buy Rating MT
03:16pm Nvidia in Talks to Back $250 Billion OpenAI Data Center Project MT
03:15pm Citic Securities Upgrades Intel to Buy From Add, Adjusts Price Target to $136 From $82 MT
03:05pm Microsoft-Backed OpenAI Agent Sandbox Breach, Hugging Face Hack was Not Caught for a Week MT
03:05pm SoftBank Group Secures New Lenders for $40 Billion Loan Targeting OpenAI Stakes MT
02:49pm Jefferies Adjusts Price Target on Apple to $308.92 From $299.88, Maintains Hold Rating MT
02:42pm Astrazeneca's Ultomiris Misses Primary Goal in Late-Stage Rare-Disease Trial MT
02:37pm AstraZeneca CFO says AI is not expected to lead to job cuts RE
02:31pm AstraZeneca Reports 'Positive' Phase 3 Results for Sonesitatug Vedotin in Claudin 18.2-Positive Gastric Cancers MT
02:12pm AstraZeneca Logs Higher First-half Profit on Strong Oncology, Rare Disease Drugs Sales; Outlook Maintained MT
01:40pm AstraZeneca quarterly earnings top hopes amid mixed pipeline updates AN
01:10pm AstraZeneca Q2 Core Earnings, Revenue Rise MT
12:30pm AstraZeneca's rare disease drug misses main goal in late-stage trial RE
12:26pm AstraZeneca Posts Sales Growth on Oncology Strength DJ
12:15pm AstraZeneca's Sone-Ve Meets Overall Survival Endpoints of Late-stage Gastric Cancer Study MT
12:05pm AstraZeneca's Ultomiris Misses Primary Endpoint in Late-stage Thrombotic Microangiopathy Trial MT
No results match your criteria